1. Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. Issue 20 (10th July 2022) Authors: Eckstein, Olive S.; Allen, Carl E.; Williams, P. Mickey; Roy-Chowdhuri, Sinchita; Patton, David R.; Coffey, Brent; Reid, Joel M.; Piao, Jin; Saguilig, Lauren; Alonzo, Todd A.; Berg, Stacey L.; Ramirez, Nilsa C.; Jaju, Alok; Mhlanga, Joyce; Fox, Elizabeth; Hawkins, Douglas S.; Mooney, Margaret M.;... Journal: Journal of clinical oncology Issue: Volume 40:Issue 20(2022) Page Start: 2235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. Issue 20 (10th July 2022) Authors: Eckstein, Olive S.; Allen, Carl E.; Williams, P. Mickey; Roy-Chowdhuri, Sinchita; Patton, David R.; Coffey, Brent; Reid, Joel M.; Piao, Jin; Saguilig, Lauren; Alonzo, Todd A.; Berg, Stacey L.; Ramirez, Nilsa C.; Jaju, Alok; Mhlanga, Joyce; Fox, Elizabeth; Hawkins, Douglas S.; Mooney, Margaret M.;... Journal: Journal of clinical oncology Issue: Volume 40:Issue 20(2022) Page Start: 2235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗